http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019213268-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2542d75d4a3ed46d8a8c7dc95803b03a |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate | 2019-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21fd83a7bd90935dd8323e8bd6db187f |
| publicationDate | 2019-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2019213268-A1 |
| titleOfInvention | Ready-to-use liquid parenteral formulations of ribavirin |
| abstract | Stable ready to use pharmaceutical compositions of Ribavirin including a primary packaging container containing a sterile aqueous Ribavirin solution having a concentration of 10 mg/mL to 40 mg/mL Ribavirin and a seal sealing the primary packaging container. The Ribavirin solution is free of viable microbial contamination in in accordance with the test methods in 40 USP <71> using Trypticase Soy Broth and Fluid Thioglycollate Medium. A method of manufacturing ready to use Ribavirin solutions by terminally sterilizing a Ribavirin solution. Methods of treating respiratory syncytial virus by administering ready to use 20 mg/mL Ribavirin solutions in a nebulizer. |
| priorityDate | 2018-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.